Recurrent neural network-based model predictive control for continuous pharmaceutical manufacturing (Q1634707): Difference between revisions
From MaRDI portal
Created a new Item |
Created claim: Wikidata QID (P12): Q128954910, #quickstatements; #temporary_batch_1724703925167 |
||
(6 intermediate revisions by 6 users not shown) | |||
Property / describes a project that uses | |||
Property / describes a project that uses: Adam / rank | |||
Normal rank | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Property / OpenAlex ID | |||
Property / OpenAlex ID: W2883194111 / rank | |||
Normal rank | |||
Property / arXiv ID | |||
Property / arXiv ID: 1807.09556 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Advanced control of industrial processes. Structures and algorithms. / rank | |||
Normal rank | |||
Property / Wikidata QID | |||
Property / Wikidata QID: Q128954910 / rank | |||
Normal rank | |||
links / mardi / name | links / mardi / name | ||
Latest revision as of 21:32, 26 August 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Recurrent neural network-based model predictive control for continuous pharmaceutical manufacturing |
scientific article |
Statements
Recurrent neural network-based model predictive control for continuous pharmaceutical manufacturing (English)
0 references
18 December 2018
0 references
Summary: The pharmaceutical industry has witnessed exponential growth in transforming operations towards continuous manufacturing to increase profitability, reduce waste and extend product ranges. Model Predictive Control (MPC) can be applied to enable this vision by providing superior regulation of Critical Quality Attributes (CQAs). For MPC, obtaining a workable system model is of fundamental importance, especially if complex process dynamics and reaction kinetics are present. Whilst physics-based models are desirable, obtaining models that are effective and fit-for-purpose may not always be practical, and industries have often relied on data-driven approaches for system identification instead. In this work, we demonstrate the applicability of Recurrent Neural Networks (RNNs) in MPC applications in continuous pharmaceutical manufacturing. RNNs were shown to be especially well-suited for modeling dynamical systems due to their mathematical structure, and their use in system identification has enabled satisfactory closed-loop performance for MPC of a complex reaction in a single Continuous-Stirred Tank Reactor (CSTR) for pharmaceutical manufacturing.
0 references
pharmaceuticals
0 references
critical quality attributes (CQAs)
0 references
recurrent neural networks
0 references
model predictive control (MPC)
0 references
system identification
0 references